Data builds behind Moderna's skin cancer vaccine Five-year results with Moderna/MSD's melanoma jab show a 49% reduction in disease progression or death, boding well for phase 3 data later this year.

#Moderna #skincancervaccine #MSD #mRNAbasedvaccine #melanoma #intismeranautogene #mRNA4157 #KEYNOTE942study #cancervaccine #highriskmelanoma #personalisedvaccine #cancerneoantigens #lungcancer #kidneycancer #bladdercancer #INTerpath001trial #solidtumours #oncology #clinicaldevelopment
zurl.co/fwe5k

AstraZeneca pays $630m to get full control of AbelZeta CAR-T AstraZeneca's push into CAR-T therapies for cancer has continued with an agreement to take full control of C-CAR031 from Chinese partner AbelZeta.

#AstraZeneca's push into #CART therapies for #cancer has continued with an agreement to take full control of C-CAR031, an #antiGPC3 therapy for #solidtumours, from #AbelZeta.

pharmaphorum.com/news/astraze...

Now Iktos teams up with Pierre Fabre in oncology As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos

#Iktos #PierreFabre #oncology #PierreFabreLaboratories #AIdrugdiscovery #roboticsdrugdiscovery #smallmoleculedrugcandidates #generativeAI #EICAccelerator #PierreFabreMedicalCare #generativeAI #precisiononcology #NSCLC #nonsmallcelllungcancer #solidtumours #rarediseases
zurl.co/Gx2yL

AbbVie unveils new data on solid tumour therapies - PharmaTimes Phase 1 and phase 2 results highlight promise of ADCs for hard-to-treat cancers

#oncology #AbbVie #solidtumourtherapies #ADCs #antibodydrugconjugate #ADCplatform #solidtumours #ESMO2025 #pancreaticcancer #colorectalcancer #solidtumourtypes #ADCcandidates #clinicaldevelopment #innovativetherapies #patientoutcomes #clinicalstrategies #regulatory
zurl.co/AmIT3

eXmoor and Signadori Bio enter cell therapy partnership - PharmaTimes Signadori is advancing a platform designed to overcome the challenges of treating solid cancers

#Celltherapy #eXmoorpharma #SignadoriBio #solidtumours #Signadori #solidcancers #genemodifiedmonocytederivedmacrophagecelltherapyprogramme #cellandgenetherapy #genemodifiedmonocytes #translationalscience #nextgenerationmonocytebasedtherapies
pharmatimes.com/news/exmoor-...

📄 [Press Release] - MaaT Pharma Presents Peclinical Data at AACR Annual Meeting Demonstrating Immune Activation and Anti-Tumor Activity of MaaT034

👉 Read the press release: www.maatpharma.com/april-28-202...

#Oncology #Microbiome #AACR #Preclinical #InVivo #InVitro #SolidTumours #Immunotherapies

Adoptive T-cell therapies are promising, but fall short in longer-term tumour clearance, with poor efficacy against #SolidTumours 📉

This new article explores how #optogenetics are being applied to improve #ATC therapies 👉 bit.ly/3Poqw5o

Bayer begins inhibitor study treating advanced KRAS-mutated tumours - PharmaTimes Trial explores potential of therapy in treating multiple cancer types

#Bayer #precisiononcology #oncology #SOS1inhibitorstudy #BAY3498264 #KRASmutatedcancers #nonsmallcelllungcancer #lungcancer #NSCLC #pancreaticcancer #colorectalcancer #MAPKsignallingpathway #KRAStargetingagent #KRASmutatedcancers #solidtumours
pharmatimes.com/news/bayer-b...

📈 #RWE publications evaluating #targetedtherapies in pts w/ #solidtumours

#RWD quality standards & ⬆️ collaboration will be 🔑 to increase the relevance of #RWE for informing clinical practice and decision making 🌍